Market Overview

Sterne Agee Reiterates Buy on PacWest Bancorp Following CSE Merger Announcement

Related PACW
Biotechs Among Stocks That Insiders Have Been Buying Lately
Benzinga's Top Initiations

In a report published Friday, Sterne Agee analyst Todd L. Hagerman reiterated a Buy rating and $45.00 price target on PacWest Bancorp (NASDAQ: PACW).

In the report, Sterne Agee noted, “Reiterating our BUY rating as the announced PACW/CSE merger continues apace. Given PACW's strong track record in executing/integrating acquisitions, in addition to the highly complementary pieces of the recently announced deal, our sense is this transformational acquisition may exceed conservative expectations.”

PacWest Bancorp closed on Thursday at $33.92.

Latest Ratings for PACW

Oct 2015Piper JaffrayInitiates Coverage onOverweight
May 2015BMO CapitalInitiates Coverage onOutperform
Mar 2015Keefe Bruyette & WoodsMaintainsOutperform

View More Analyst Ratings for PACW
View the Latest Analyst Ratings

Posted-In: Sterne Agee Todd L. HagermanAnalyst Color Reiteration Analyst Ratings


Related Articles (PACW)

View Comments and Join the Discussion!

Get Benzinga's Newsletters